Nyberg Reita H, Korkola Pasi, Mäenpää Johanna U
*Department of OB&GYN, Tampere University Hospital; †Department of Nuclear Medicine, Medical Imaging Centre; and ‡Department of OB&GYN, Tampere University Hospital, Pirkanmaa Hospital District; and School of Medicine, University of Tampere, Tampere, Finland.
Int J Gynecol Cancer. 2017 May;27(4):684-689. doi: 10.1097/IGC.0000000000000948.
Intraoperative detection of ovarian sentinel nodes has been shown to be feasible. We examined the detection rate and locations of sentinel nodes in patients with ovarian tumors. We also aimed to assess the reliability of sentinel node method in predicting regional lymph node metastasis.
Twenty patients scheduled for laparotomy because of a pelvic mass were recruited to the study. In the beginning of the laparotomy, radioisotope and blue dye were injected under the serosa next to the junction of the ovarian tumor and suspensory ligament. The number and locations of the hot and/or blue nodes/spots were recorded during the operation. If the tumor was malignant according to the frozen section, systematic lymphadenectomies were performed, the sentinel nodes sampled separately, and their status compared with other regional lymph nodes.
Eleven patients had a right-sided ovarian tumor, 7 patients a left-sided tumor, and 2 patients had bilateral tumors. A median of 2 sentinel nodes/locations per patient (range, 1-3) were found. Sixty percent of all sentinel nodes were located in the para-aortic region only, compared with 30% in both para-aortic and pelvic areas and 10% in pelvic area only. Both unilateral and bilateral locations were found. In 83% of the cases with more than 1 sentinel node location, they were located in separate anatomical regions. In 3 patients, systematic lymphadenectomies were performed. One of them had nodal metastases in 2 regions and also a metastasis in 1 of her 2 sentinel nodes in 1 of those regions.
In patients with ovarian tumor(s), the detection of sentinel nodes is feasible. They are located in different anatomic areas both ipsilaterally and contralaterally, although most of them are found in the para-aortic region. The reliability of the sentinel node concept should be evaluated in the framework of a multicenter trial.
术中检测卵巢前哨淋巴结已被证明是可行的。我们研究了卵巢肿瘤患者前哨淋巴结的检出率及位置。我们还旨在评估前哨淋巴结法预测区域淋巴结转移的可靠性。
招募20例因盆腔肿块计划行剖腹手术的患者参与本研究。在剖腹手术开始时,在卵巢肿瘤与悬韧带交界处旁的浆膜下注射放射性同位素和蓝色染料。术中记录热和/或蓝色淋巴结/斑点的数量及位置。如果根据冰冻切片肿瘤为恶性,则行系统性淋巴结清扫术,单独采集前哨淋巴结,并将其状态与其他区域淋巴结进行比较。
11例患者为右侧卵巢肿瘤,7例为左侧肿瘤,2例为双侧肿瘤。每位患者发现的前哨淋巴结/位置中位数为2个(范围1 - 3个)。所有前哨淋巴结中,60%仅位于腹主动脉旁区域,相比之下,30%位于腹主动脉旁和盆腔区域,10%仅位于盆腔区域。发现了单侧和双侧位置。在83%有多个前哨淋巴结位置的病例中,它们位于不同的解剖区域。3例患者行系统性淋巴结清扫术。其中1例患者在2个区域有淋巴结转移,且在其中1个区域的2个前哨淋巴结中有1个发生转移。
在卵巢肿瘤患者中,检测前哨淋巴结是可行的。它们位于同侧和对侧的不同解剖区域,尽管大多数位于腹主动脉旁区域。前哨淋巴结概念的可靠性应在多中心试验的框架内进行评估。